# The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction

> **NCT00240045** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Alberta** · enrollment: 9 (actual)

## Conditions studied

- Type 2 Hepatorenal Syndrome
- Refractory Ascites

## Interventions

- **DRUG:** Midodrine, albumin, octreotide LAR
- **DRUG:** midodrine, octreotide, albumin

## Key facts

- **NCT ID:** NCT00240045
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2007-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240045, "The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00240045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*